Previous 10 | Next 10 |
home / stock / clpbf / clpbf news
2023-05-11 16:18:03 ET Coloplast A/S (CLPBF) First Half 2022-2023 Earnings Conference Call May 11, 2023 5:00 AM ET Company Participants Kristian Villumsen – President and Chief Executive Officer Anders Lonning-Skovgaard – Chief Financial Officer C...
2023-05-11 10:15:00 ET Coloplast ASB ( OTCPK:CLPBF ): Q2 Non-GAAP EPS of DKK5.51. Revenue of DKK6.06B (+10.2% Y/Y) For further details see: Coloplast ASB Non-GAAP EPS of DKK5.51, revenue of DKK6.06B
2023-04-20 08:54:20 ET Summary Coloplast is growing with extreme consistency and first quarter results were in-line again with previous top line growth. The company is not only growing with high consistency but also has extremely stable margins and is reporting an extremely high r...
Coloplast A/S (CLPBF) Q1 2023 Earnings Conference Call February 03, 2023 05:00 AM ET Company Participants Kristian Villumsen - President and CEO Anders Lonning-Skovgaard - CFO Conference Call Participants Hassan Al-Wakeel - Barclays Maja Pataki - Kepler Che...
The following slide deck was published by Coloplast A/S in conjunction with their 2023 Q1 earnings call. For further details see: Coloplast A/S 2023 Q1 - Results - Earnings Call Presentation
Coloplast ASB press release ( OTCPK:CLPBF ): Q1 GAAP EPS of DKK5.31. Revenue of DKK6.1B (+18.2% Y/Y). For further details see: Coloplast ASB GAAP EPS of DKK5.31, revenue of DKK6.1B
Summary Coloplast reported full-year results with high growth for revenue, but slightly declining earnings per share. The company has not only a wide economic moat around its business, but is also recession resilient and expecting to grow in the high single digits. Nevertheles...
Coloplast A/S (CLPBF) Q4 2022 Earnings Conference Call November 07, 2022 09:00 AM ET Company Participants Kristian Villumsen - President & Chief Executive Officer Anders Lonning-Skovgaard - Chief Financial Officer Conference Call Participants Hassan A...
Coloplast ASB press release ( OTCPK:CLPBF ): Q4 GAAP EPS of $22.11. Revenue of $6.05B (+20.8% Y/Y) beats by $3.04B . For further details see: Coloplast ASB GAAP EPS of $22.11, revenue of $6.05B beats by $3.04B
The following slide deck was published by Coloplast A/S in conjunction with their 2022 Q4 earnings call. For further details see: Coloplast A/S 2022 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Coloplast A/S Company Name:
CLPBF Stock Symbol:
OTCMKTS Market:
The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients. “We are now introducing new innovation to the US market, aiming to grow our presence within the foam dressings segment...